<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="21aea811-f47d-4a44-a552-dfc46d2773bf"><labelDrug name="Betapace AF"><Normalization><mmtx cui="C0875976" preferredWord="Betapace AF" semType="phsu, orch"/></Normalization></labelDrug><generic name="sotalol hydrochloride"/><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.1" text="BETAPACE AF (sotalol hydrochloride) tablet" type="negative"><entity charOffset="0:11" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.1.e.0" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="BETAPACE AF (sotalol hydrochloride" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="13:34" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.1.e.1" text="sotalol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0026289" phraseText="BETAPACE AF (sotalol hydrochloride" preferredWord="Sotalol Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.1.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.1.e.1"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.2" text="Betapace AF, (sotalol hydrochloride), is an antiarrhythmic drug with Class II (beta-adrenoreceptor blocking) and Class III (cardiac action potential duration prolongation) properties." type="negative"><entity charOffset="0:11" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.2.e.0" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="Betapace AF," preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="44:77" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.2.e.1" text="antiarrhythmic drug class ii" type="Biomedical_Entity"><Normalization><mmtx cui="C0360701" phraseText="an antiarrhythmic drug with Class II" preferredWord="Class II antiarrhythmic drug" semType="phsu"/><RxNorm RxCui="883"/></Normalization></entity><entity charOffset="14:35" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.2.e.2" text="sotalol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0026289" phraseText="(sotalol hydrochloride" preferredWord="Sotalol Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.2.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.2.e.1"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.2.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.2.e.2"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.2.e.2" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.2.e.1"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.4" text="Betapace AF (sotalol hydrochloride) is contraindicated in patients with sinus bradycardia (&lt;50 bpm during waking hours), sick sinus syndrome or second and third degree AV block (unless a functioning pacemaker is present), congenital or acquired long QT syndromes, baseline QT interval &gt;450 msec, cardiogenic shock, uncontrolled heart failure, hypokalemia (&lt;4 meq/L), creatinine clearance &lt;40 mL/min, bronchial asthma and previous evidence of hypersensitivity to sotalol." type="negative"><entity charOffset="0:11" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.4.e.0" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="Betapace AF (sotalol hydrochloride" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="462:469" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.4.e.1" text="sotalol" type="Biomedical_Entity"><Normalization><mmtx cui="C0037707" phraseText="to sotalol." preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><entity charOffset="13:34" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.4.e.2" text="sotalol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0026289" phraseText="Betapace AF (sotalol hydrochloride" preferredWord="Sotalol Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.4.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.4.e.1"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.4.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.4.e.2"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.4.e.2" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.4.e.1"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.7" text="Betapace AF (sotalol) can cause serious ventricular arrhythmias, primarily Torsade de Pointes (TdP) type ventricular tachycardia, a polymorphic ventricular tachycardia associated with QT interval prolongation. " type="negative"><entity charOffset="0:11" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.7.e.0" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="Betapace AF (sotalol" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="13:20" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.7.e.1" text="sotalol" type="Biomedical_Entity"><Normalization><mmtx cui="C0037707" phraseText="Betapace AF (sotalol" preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.7.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.7.e.1"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.22" text="Proarrhythmia in Ventricular Arrhythmia Patients: [see Betapace (sotalol hydrochloride) Package Insert]" type="negative"><entity charOffset="65:86" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.22.e.0" text="sotalol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0026289" phraseText="(sotalol hydrochloride" preferredWord="Sotalol Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><entity charOffset="55:63" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.22.e.1" text="betapace" type="Biomedical_Entity"><Normalization><mmtx cui="C0728751" phraseText="Betapace" preferredWord="Betapace" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.22.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.22.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.35" lineNumber="35" text="The use of Betapace AF in conjunction with other drugs that prolong the QT interval has not been studied and is not recommended. " type="regular"><entity charOffset="112:127" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.35.e.0" text="not recommended" type="Caution_Interaction"/><entity charOffset="11:22" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.35.e.2" text="Betapace AF" type="Drug"><Normalization><mmtx cui="C0875976" phraseText="The use of Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="49:83" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.35.e.3" text="drugs that prolong the QT interval" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="in conjunction with other drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.35.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.35.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.35.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.35.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.35.e.2" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.35.e.3" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.35.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36" text="Such drugs include many antiarrhythmics, some phenothiazines, bepridil, tricyclic antidepressants, and certain oral macrolides. " type="negative"><entity charOffset="72:97" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.0" text="tricyclic antidepressants" type="Biomedical_Entity"><Normalization><mmtx cui="C0003290" phraseText="tricyclic antidepressants," preferredWord="Tricyclic Antidepressive Agents" semType="phsu"/><RxNorm RxCui="928"/></Normalization></entity><entity charOffset="24:39" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.1" text="antiarrhythmics" type="Biomedical_Entity"><Normalization><mmtx cui="C0003195" phraseText="many antiarrhythmics," preferredWord="Anti-Arrhythmia Agents" semType="phsu"/><RxNorm RxCui="883"/></Normalization></entity><entity charOffset="116:126" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.2" text="macrolides" type="Biomedical_Entity"><Normalization><mmtx cui="C0282563" phraseText="certain oral macrolides." preferredWord="Macrolides" semType="phsu, orch"/><RxNorm RxCui="1437086"/></Normalization></entity><entity charOffset="62:70" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.3" text="bepridil" type="Biomedical_Entity"><Normalization><mmtx cui="C0005116" phraseText="bepridil," preferredWord="Bepridil" semType="phsu, orch"/><RxNorm RxCui="1436"/></Normalization></entity><entity charOffset="46:60" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.4" text="phenothiazines" type="Biomedical_Entity"><Normalization><mmtx cui="C0031434" phraseText="some phenothiazines," preferredWord="phenothiazine" semType="phsu, orch"/><RxNorm RxCui="1437064"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.0"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.2"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.3" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.0"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.4" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.0"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.2"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.3"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.4"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.3" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.2"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.4" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.2"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.4" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.36.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.37" lineNumber="35" text="Class I or Class III antiarrhythmic agents should be withheld for at least three half-lives prior to dosing with Betapace AF. " type="regular"><entity charOffset="0:42" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.37.e.0" text="Class I or Class III antiarrhythmic agents" type="Drug_Class"><Normalization><mmtx cui="C0360703" phraseText="Class III antiarrhythmic agents" preferredWord="Class III antiarrhythmic drug" semType="phsu"/><RxNorm RxCui="5716"/></Normalization></entity><entity charOffset="53:61|92:97" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.37.e.1" text="withheld prior" type="Caution_Interaction"/><entity charOffset="113:124" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.37.e.3" text="Betapace AF" type="Drug"><Normalization><mmtx cui="C0875976" phraseText="with Betapace AF." preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.37.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.37.e.1"><relations><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.37.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.37.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.37.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.37.e.3" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.37.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.38" text="In clinical trials, Betapace AF was not administered to patients previously treated with oral amiodarone for &gt;1 month in the previous three months. " type="negative"><entity charOffset="20:31" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.38.e.0" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="94:104" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.38.e.1" text="amiodarone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002598" phraseText="treated with oral amiodarone" preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.38.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.38.e.1"/></sentence><sentence biomedicalEntities="7" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39" lineNumber="35" text="Class Ia antiarrhythmic drugs, such as disopyramide, quinidine and procainamide and other Class III drugs (e.g., amiodarone) are not recommended as concomitant therapy with Betapace AF because of their potential to prolong refractoriness (see WARNINGS). " type="regular"><anaphoraRelation><anaphoraEntity charOffset="196:201" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.13" text="their" type="Expression"/><antecedentEntity charOffset="0-29" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.0" text="Class Ia antiarrhythmic drugs" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="196:201" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.13" text="their" type="Expression"/><antecedentEntity charOffset="90-105" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.4" text="Class III drugs" type="Drug_Class"/></anaphoraRelation><entity charOffset="0:29" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.0" text="Class Ia antiarrhythmic drugs" type="Drug_Class"><Normalization><mmtx cui="C0304503" phraseText="Class Ia antiarrhythmic drugs," preferredWord="Class Ia antiarrhythmic drug" semType="phsu"/><RxNorm RxCui="5716"/></Normalization></entity><entity charOffset="39:51" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.1" text="disopyramide" type="Drug"><Normalization><mmtx cui="C0012702" phraseText="such as disopyramide," preferredWord="Disopyramide" semType="phsu, orch"/><RxNorm RxCui="3541"/></Normalization></entity><entity charOffset="53:62" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.2" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="67:79" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.3" text="procainamide" type="Drug"><Normalization><mmtx cui="C0033216" phraseText="procainamide" preferredWord="Procainamide" semType="phsu, orch"/><RxNorm RxCui="155056"/></Normalization></entity><entity charOffset="90:105" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.4" text="Class III drugs" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="other Class III drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="5716"/></Normalization></entity><entity charOffset="113:123" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.5" text="amiodarone" type="Drug"><Normalization><mmtx cui="C0002598" phraseText="amiodarone" preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><entity charOffset="173:184" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.10" text="Betapace AF" type="Drug"><Normalization><mmtx cui="C0875976" phraseText="with Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="202:237" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.11" text="potential to prolong refractoriness" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.1" drugClass="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.0"/><drugClassMembership drug="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.2" drugClass="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.0"/><drugClassMembership drug="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.3" drugClass="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.0"/><drugClassMembership drug="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.5" drugClass="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.4"/><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.11"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.13"/></relation><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.10"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.10" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.13" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.39.e.11" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43" lineNumber="39" text="In patients who have heart failure controlled by digitalis and/or diuretics, Betapace AF should be administered cautiously. " type="regular"><entity charOffset="77:88" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.0" text="Betapace AF" type="Drug"><Normalization><mmtx cui="C0875976" phraseText="Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="21:34" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.1" text="heart failure" type="SPAN"><Normalization><mmtx cui="C0018801" phraseText="heart failure" preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="heart failure" preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><entity charOffset="99:122" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.2" text="administered cautiously" type="Caution_Interaction"/><entity charOffset="49:58" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.4" text="digitalis" type="Drug"><Normalization><mmtx cui="C0304520" phraseText="controlled by digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="66:75" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.5" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.1" ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.4" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.0" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.2" type="Caution_Interaction"/><pair context="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.1" ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.5" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.0" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.2" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.4" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.43.e.5"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.44" text="Both digitalis and sotalol slow AV conduction. " type="negative"><entity charOffset="19:26" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.44.e.0" text="sotalol" type="Biomedical_Entity"><Normalization><mmtx cui="C0037707" phraseText="sotalol slow AV conduction." preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><entity charOffset="5:14" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.44.e.1" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="Both digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.44.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.44.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.54" lineNumber="43" text="Special attention should be given to electrolyte and acid-base balance in patients experiencing severe or prolonged diarrhea or patients receiving concomitant diuretic drugs." type="irregular"><entity charOffset="159:173" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.54.e.0" text="diuretic drugs" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="concomitant diuretic drugs." preferredWord="Diuretics" semType="phsu"/><mmtx cui="C0013227" phraseText="concomitant diuretic drugs." preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="0:17" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.54.e.1" text="Special attention" type="Caution_Interaction"/><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.54.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.54.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.53" text="Betapace AF should not be used in patients with hypokalemia or hypomagnesemia prior to correction of imbalance, as these conditions can exaggerate the degree of QT prolongation, and increase the potential for Torsade de Pointes. "><entity charOffset="0:11" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.53.e.0" text="Betapace AF" type="Drug"><Normalization><mmtx cui="C0875976" phraseText="Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.54.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.54.e.0"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.63" text="Hypersensitivity to catecholamines has been observed in patients withdrawn from beta-blocker therapy. " type="negative"><entity charOffset="80:92" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.63.e.0" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="withdrawn from beta-blocker therapy." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="20:34" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.63.e.1" text="catecholamines" type="Biomedical_Entity"><Normalization><mmtx cui="C0007412" phraseText="Hypersensitivity to catecholamines" preferredWord="Catecholamines" semType="phsu, nsba"/><RxNorm RxCui="2146"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.63.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.63.e.0"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.65" text="Therefore, it is prudent when discontinuing chronically administered Betapace AF, particularly in patients with ischemic heart disease, to carefully monitor the patient and consider the temporary use of an alternate beta-blocker if appropriate. " type="negative"><entity charOffset="69:80" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.65.e.0" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="chronically administered Betapace AF," preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="216:228" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.65.e.1" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="the temporary use of an alternate beta-blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.65.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.65.e.1"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.72" text="It is prudent, if Betapace AF (sotalol hydrochloride) is to be administered, to use the smallest effective dose, so that inhibition of bronchodilation produced by endogenous or exogenous catecholamine stimulation of beta2 receptors may be minimized." type="negative"><entity charOffset="187:200" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.72.e.0" text="catecholamine" type="Biomedical_Entity"><Normalization><mmtx cui="C3536742" phraseText="exogenous catecholamine stimulation of beta2 receptors" preferredWord="Catecholamine [EPC]" semType="phsu"/><RxNorm RxCui="2146"/></Normalization></entity><entity charOffset="31:52" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.72.e.1" text="sotalol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0026289" phraseText="Betapace AF (sotalol hydrochloride" preferredWord="Sotalol Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><entity charOffset="18:29" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.72.e.2" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="Betapace AF (sotalol hydrochloride" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.72.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.72.e.0"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.72.e.2" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.72.e.0"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.72.e.2" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.72.e.1"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.74" text="While taking beta-blockers, patients with a history of anaphylactic reaction to a variety of allergens may have a more severe reaction on repeated challenge, either accidental, diagnostic or therapeutic. " type="negative"><entity charOffset="13:26" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.74.e.0" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="taking beta-blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="93:102" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.74.e.1" text="allergens" type="Biomedical_Entity"><Normalization><mmtx cui="C3274161" phraseText="of allergens" preferredWord="Allergen (brand of diphenylpyraline)" semType="phsu, orch"/><RxNorm RxCui="1297244"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.74.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.74.e.1"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.79" text="In patients with diabetes (especially labile diabetes) or with a history of episodes of spontaneous hypoglycemia, Betapace AF should be given with caution since beta-blockade may mask some important premonitory signs of acute hypoglycemia; " type="negative"><entity charOffset="114:125" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.79.e.0" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="166:174" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.79.e.1" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="beta-blockade" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.79.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.79.e.1"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.92" text="Betapace AF (sotalol hydrochloride) is eliminated principally via the kidneys through glomerular filtration and to a small degree by tubular secretion. " type="negative"><entity charOffset="13:34" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.92.e.0" text="sotalol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0026289" phraseText="Betapace AF (sotalol hydrochloride" preferredWord="Sotalol Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.92.e.1" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="Betapace AF (sotalol hydrochloride" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.92.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.92.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98" lineNumber="93" text="The patient should be fully instructed on the need for compliance with the recommended dosing of Betapace AF, the potential interactions with drugs that prolong the QT interval and other antiarrhythmics, and the need for periodic monitoring of QT and renal function to minimize the risk of serious abnormal rhythms." type="regular"><entity charOffset="97:108" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.0" text="Betapace AF" type="Drug"><Normalization><mmtx cui="C0875976" phraseText="of Betapace AF," preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="142:176" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.1" text="drugs that prolong the QT interval" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="the potential interactions with drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="187:202" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.2" text="antiarrhythmics" type="Drug_Class"><Normalization><mmtx cui="C0003195" phraseText="other antiarrhythmics," preferredWord="Anti-Arrhythmia Agents" semType="phsu"/><RxNorm RxCui="883"/></Normalization></entity><entity charOffset="114:136" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.3" text="potential interactions" type="Caution_Interaction"/><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.2" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.3" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.1" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.3" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.98.e.2"/></sentence><sentence biomedicalEntities="6" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100" lineNumber="97" text="Assessment of patients' medication history should include all over-counter, prescription and herbal/natural preparations with emphasis on preparations that may affect the pharmacodynamics of Betapace AF such as other cardiac antiarrhythmic drugs, some phenothiazines, bepridil, tricyclic antidepressants and oral macrolides (see WARNINGS and Use with Drugs that Prolong QT Interval and Antiarrhythmic Agents). " type="regular"><entity charOffset="217:245" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.0" text="cardiac antiarrhythmic drugs" type="Drug_Class"><Normalization><mmtx cui="C0003195" phraseText="such as other cardiac antiarrhythmic drugs," preferredWord="Anti-Arrhythmia Agents" semType="phsu"/><RxNorm RxCui="1025351"/></Normalization></entity><entity charOffset="252:266" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.1" text="phenothiazines" type="Drug_Class"><Normalization><mmtx cui="C0031434" phraseText="some phenothiazines," preferredWord="phenothiazine" semType="phsu, orch"/><mmtx cui="C0031436" phraseText="some phenothiazines," preferredWord="Phenothiazines" semType="phsu, orch"/><mmtx cui="C0304370" phraseText="some phenothiazines," preferredWord="Phenothiazine derivatives" semType="phsu, orch"/><RxNorm RxCui="1437064"/></Normalization></entity><entity charOffset="268:276" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.2" text="bepridil" type="Drug"><Normalization><mmtx cui="C0005116" phraseText="bepridil," preferredWord="Bepridil" semType="phsu, orch"/><RxNorm RxCui="1436"/></Normalization></entity><entity charOffset="278:303" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.3" text="tricyclic antidepressants" type="Drug_Class"><Normalization><mmtx cui="C0003290" phraseText="tricyclic antidepressants" preferredWord="Tricyclic Antidepressive Agents" semType="phsu"/><RxNorm RxCui="928"/></Normalization></entity><entity charOffset="308:323" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.4" text="oral macrolides" type="Drug_Class"><Normalization><mmtx cui="C0003240" phraseText="oral macrolides" preferredWord="Macrolide Antibiotics" semType="orch, antb"/><mmtx cui="C0282563" phraseText="oral macrolides" preferredWord="Macrolides" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="191:202" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.5" text="Betapace AF" type="Drug"><Normalization><mmtx cui="C0875976" phraseText="the pharmacodynamics of Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="160:187" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.6" text="affect the pharmacodynamics" type="Specific_Interaction"/><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.6"><relations><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.5" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.1" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.6" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.5" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.3" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.6" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.5" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.2" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.6" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.5" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.0" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.6" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.3"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.2"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.1"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.2" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.3"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.3"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.100.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.114" lineNumber="115" text="Proarrhythmic events were more common in sotalol treated patients also receiving digoxin; " type="regular"><entity charOffset="41:48" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.114.e.0" text="sotalol" type="Drug"><Normalization><mmtx cui="C0037707" phraseText="more common in sotalol treated patients also" preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><entity charOffset="81:88" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.114.e.1" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="0:20" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.114.e.2" text="Proarrhythmic events" type="Specific_Interaction"/><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.114.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.114.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.114.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.114.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.114.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.114.e.1" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.114.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.116" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. " type="negative"><entity charOffset="5:25" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.116.e.0" text="digitalis glycosides" type="Biomedical_Entity"><Normalization><mmtx cui="C0012253" phraseText="Both digitalis glycosides" preferredWord="Digitalis Glycosides" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="30:43" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.116.e.1" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers slow atrioventricular conduction" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.116.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.116.e.1"/></sentence><sentence biomedicalEntities="0" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.117" lineNumber="115" text="Concomitant use can increase the risk of bradycardia." type="irregular"><entity charOffset="41:52" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.117.e.0" text="bradycardia" type="Specific_Interaction"/><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.117.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.117.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.116" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. "><entity charOffset="5:25" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.116.e.0" text="digitalis glycosides" type="Drug_Class"><Normalization><mmtx cui="C0012253" phraseText="Both digitalis glycosides" preferredWord="Digitalis Glycosides" semType="phsu, carb"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.116" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. "><entity charOffset="30:43" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.116.e.1" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers slow atrioventricular conduction" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119" lineNumber="119" text="Betapace AF should be administered with caution in conjunction with calcium blocking drugs because of possible additive effects on atrioventricular conduction or ventricular function. " type="regular"><entity charOffset="0:11" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.0" text="Betapace AF" type="Drug"><Normalization><mmtx cui="C0875976" phraseText="Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="68:90" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.1" text="calcium blocking drugs" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="in conjunction with calcium blocking drugs" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="111:158" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.2" text="additive effects on atrioventricular conduction" type="Specific_Interaction"/><entity charOffset="111:130|162:182" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.4" text="additive effects on ventricular function" type="Specific_Interaction"/><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.ddi.2"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.1" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.120" lineNumber="119" text="Additionally, concomitant use of these drugs may have additive effects on blood pressure, possibly leading to hypotension." type="irregular"><entity charOffset="54:88" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.120.e.0" text="additive effects on blood pressure" type="Specific_Interaction"/><entity charOffset="110:121" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.120.e.2" text="hypotension" type="Specific_Interaction"/><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.120.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.120.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119" text="Betapace AF should be administered with caution in conjunction with calcium blocking drugs because of possible additive effects on atrioventricular conduction or ventricular function. "><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.1"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119" text="Betapace AF should be administered with caution in conjunction with calcium blocking drugs because of possible additive effects on atrioventricular conduction or ventricular function. "><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.120.ddi.2"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.120.e.2"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119" text="Betapace AF should be administered with caution in conjunction with calcium blocking drugs because of possible additive effects on atrioventricular conduction or ventricular function. "><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.1"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119" text="Betapace AF should be administered with caution in conjunction with calcium blocking drugs because of possible additive effects on atrioventricular conduction or ventricular function. "><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.119.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="4" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122" lineNumber="123" text="Concomitant use of catecholamine-depleting drugs, such as reserpine and guanethidine, with a beta-blocker may produce an excessive reduction of resting sympathetic nervous tone. " type="regular"><entity charOffset="19:48" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.0" text="catecholamine-depleting drugs" type="Drug_Class"><Normalization><mmtx cui="C0007412" phraseText="Concomitant use of catecholamine-depleting drugs," preferredWord="Catecholamines" semType="phsu, nsba"/><mmtx cui="C0013227" phraseText="Concomitant use of catecholamine-depleting drugs," preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C3536742" phraseText="Concomitant use of catecholamine-depleting drugs," preferredWord="Catecholamine [EPC]" semType="phsu"/><mmtx cui="C0013227" phraseText="Concomitant use of catecholamine-depleting drugs," preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="990350"/></Normalization></entity><entity charOffset="58:67" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.1" text="reserpine" type="Drug"><Normalization><mmtx cui="C0035179" phraseText="such as reserpine" preferredWord="Reserpine" semType="phsu, orch"/><RxNorm RxCui="9260"/></Normalization></entity><entity charOffset="72:84" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.2" text="guanethidine" type="Drug"><Normalization><mmtx cui="C0018318" phraseText="guanethidine," preferredWord="Guanethidine" semType="phsu, orch"/><RxNorm RxCui="5036"/></Normalization></entity><entity charOffset="93:105" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.3" text="beta-blocker" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="with a beta-blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="131:176" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.6" text="reduction of resting sympathetic nervous tone" type="Specific_Interaction"><Normalization><mmtx cui="C0027769" phraseText="an excessive reduction of resting sympathetic nervous tone." preferredWord="Nervousness" semType="sosy"/></Normalization></entity><drugClassMembership drug="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.1" drugClass="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.0"/><drugClassMembership drug="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.2" drugClass="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.0"/><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.6"><relations><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.3" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.122.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123" lineNumber="123" text="Patients treated with Betapace AF plus a catecholamine depletor should therefore be closely monitored for evidence of hypotension and/or marked bradycardia which may produce syncope." type="regular"><entity charOffset="22:33" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.0" text="Betapace AF" type="Drug"><Normalization><mmtx cui="C0875976" phraseText="treated with Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="41:63" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.1" text="catecholamine depletor" type="Drug_Class"><Normalization><mmtx cui="C0007412" phraseText="plus a catecholamine depletor" preferredWord="Catecholamines" semType="phsu, nsba"/><mmtx cui="C3536742" phraseText="plus a catecholamine depletor" preferredWord="Catecholamine [EPC]" semType="phsu"/><RxNorm RxCui="1451215"/></Normalization></entity><entity charOffset="118:129" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.2" text="hypotension" type="Specific_Interaction"/><entity charOffset="144:155" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.4" text="bradycardia" type="Specific_Interaction"/><entity charOffset="174:181" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.6" text="syncope" type="Specific_Interaction"><Normalization><mmtx cui="C0039070" phraseText="syncope." preferredWord="Syncope" semType="sosy"/></Normalization></entity><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.ddi.2"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.ddi.3"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.1" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.124" text="Insulin and oral antidiabetics" type="negative"><entity charOffset="0:7" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.124.e.0" text="insulin" type="Biomedical_Entity"><Normalization><mmtx cui="C1533581" phraseText="Insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="17:30" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.124.e.1" text="antidiabetics" type="Biomedical_Entity"><Normalization><mmtx cui="C0935929" phraseText="oral antidiabetics" preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.124.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.124.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.125" lineNumber="127" text="Hyperglycemia may occur, and the dosage of insulin or antidiabetic drugs may require adjustment. " type="irregular"><entity charOffset="0:13" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.125.e.0" text="Hyperglycemia" type="Specific_Interaction"><Normalization><mmtx cui="C0020456" phraseText="Hyperglycemia" preferredWord="Hyperglycemia" semType="dsyn"/></Normalization></entity><entity charOffset="43:50" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.125.e.2" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="the dosage of insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="the dosage of insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="the dosage of insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="54:72" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.125.e.3" text="antidiabetic drugs" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="antidiabetic drugs" preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.125.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.125.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.125.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123" text="Patients treated with Betapace AF plus a catecholamine depletor should therefore be closely monitored for evidence of hypotension and/or marked bradycardia which may produce syncope."><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.123.e.0"/></ellipsisSentence><middleSentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.124" text="Insulin and oral antidiabetics"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.125.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.125.e.2" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.125.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.125.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.125.e.3"/></sentence><sentence biomedicalEntities="5" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128" lineNumber="131" text="Beta-agonists such as salbutamol, terbutaline and isoprenaline may have to be administered in increased dosages when used concomitantly with Betapace AF." type="regular"><entity charOffset="141:152" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.0" text="Betapace AF" type="Drug"><Normalization><mmtx cui="C0875976" phraseText="concomitantly with Betapace AF." preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="78:111" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.1" text="administered in increased dosages" type="Decrease_Interaction"/><entity charOffset="0:13" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.3" text="Beta-agonists" type="Drug_Class"><Normalization><mmtx cui="C0243192" phraseText="Beta-agonists such as salbutamol," preferredWord="agonists" semType="phsu"/><mmtx cui="C2987634" phraseText="Beta-agonists such as salbutamol," preferredWord="Agonist" semType="phsu"/><RxNorm RxCui="1437024"/></Normalization></entity><entity charOffset="22:32" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.4" text="salbutamol" type="Drug"><Normalization><mmtx cui="C0001927" phraseText="Beta-agonists such as salbutamol," preferredWord="Albuterol" semType="phsu, orch"/><mmtx cui="C0001927" phraseText="Beta-agonists such as salbutamol," preferredWord="Albuterol" semType="phsu, orch"/><RxNorm RxCui="435"/></Normalization></entity><entity charOffset="34:45" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.5" text="terbutaline" type="Drug"><Normalization><mmtx cui="C0039542" phraseText="terbutaline" preferredWord="Terbutaline" semType="phsu, orch"/><RxNorm RxCui="10368"/></Normalization></entity><entity charOffset="50:62" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.6" text="isoprenaline" type="Drug"><Normalization><mmtx cui="C0022245" phraseText="isoprenaline" preferredWord="Isoproterenol" semType="phsu, orch"/><RxNorm RxCui="6054"/></Normalization></entity><drugClassMembership drug="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.4" drugClass="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.3"/><drugClassMembership drug="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.5" drugClass="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.3"/><drugClassMembership drug="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.6" drugClass="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.3"/><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.3" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.0" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.128.e.1" type="Decrease_Interaction"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.131" text="therefore, caution is advised when discontinuing clonidine in patients receiving Betapace AF." type="negative"><entity charOffset="81:92" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.131.e.0" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="Betapace AF." preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="49:58" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.131.e.1" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="clonidine in patients" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.131.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.131.e.0"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.133" text="No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin." type="negative"><entity charOffset="51:70" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.133.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="observed with hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="74:82" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.133.e.1" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="warfarin." preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.133.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.133.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135" lineNumber="143" text="Administration of Betapace AF within 2 hours of antacids containing aluminum oxide and magnesium hydroxide should be avoided because it may result in a reduction in Cmax and AUC of 26% and 20%, respectively and consequently in a 25% reduction in the bradycardic effect at rest. " type="regular"><entity charOffset="18:29" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.0" text="Betapace AF" type="Drug"><Normalization><mmtx cui="C0875976" phraseText="Administration of Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="48:106" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.1" text="antacids containing aluminum oxide and magnesium hydroxide" type="Drug_Class"><Normalization><mmtx cui="C0003138" phraseText="of antacids" preferredWord="Antacids" semType="phsu"/><mmtx cui="C0024476" phraseText="magnesium hydroxide" preferredWord="Magnesium Hydroxide" semType="inch, phsu"/><RxNorm RxCui="863"/></Normalization></entity><entity charOffset="152:169" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.2" text="reduction in Cmax" type="Decrease_Interaction"/><entity charOffset="152:164|174:177" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.4" text="reduction in AUC" type="Decrease_Interaction"/><entity charOffset="233:276" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.6" text="reduction in the bradycardic effect at rest" type="Specific_Interaction"/><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.ddi.1"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.ddi.2"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.ddi.3"><interaction trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.1" trigger="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.135.e.2" type="Decrease_Interaction"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.136" text="Administration of the antacid two hours after Betapace AF has no effect on the pharmacokinetics or pharmacodynamics of sotalol." type="negative"><entity charOffset="22:29" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.136.e.0" text="antacid" type="Biomedical_Entity"><Normalization><mmtx cui="C0003216" phraseText="Administration of the antacid two hours" preferredWord="Anti-Ulcer Agent" semType="phsu"/><RxNorm RxCui="863"/></Normalization></entity><entity charOffset="46:57" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.136.e.1" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="after Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="119:126" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.136.e.2" text="sotalol" type="Biomedical_Entity"><Normalization><mmtx cui="C0037707" phraseText="pharmacodynamics of sotalol." preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.136.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.136.e.1"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.136.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.136.e.2"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.136.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.136.e.2"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.165" text="As proarrhythmic events can occur not only at initiation of therapy, but also with each upward dosage adjustment, Steps 2 through 5 used during initiation of Betapace AF therapy should be followed when increasing the dose level. " type="negative"><entity charOffset="114:121" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.165.e.0" text="steps 2" type="Biomedical_Entity"><Normalization><mmtx cui="C1875784" phraseText="Steps 2 through 5" preferredWord="STEP 2" semType="phsu"/><RxNorm RxCui="693226"/></Normalization></entity><entity charOffset="158:169" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.165.e.1" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="used during initiation of Betapace AF therapy" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.165.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.165.e.1"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.204" text="As in adults Betapace AF (sotalol hydrochloride) should be used with particular caution in children if the QTc is greater than 500 msec on therapy and serious consideration should be given to reducing the dose or discontinuing therapy when QTc exceeds 550 msec." type="negative"><entity charOffset="26:47" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.204.e.0" text="sotalol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0026289" phraseText="As in adults Betapace AF (sotalol hydrochloride" preferredWord="Sotalol Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><entity charOffset="13:24" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.204.e.1" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="As in adults Betapace AF (sotalol hydrochloride" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.204.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.204.e.0"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.205" text="The use of Betapace AF (sotalol hydrochloride) in children with renal impairment has not been investigated. " type="negative"><entity charOffset="11:22" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.205.e.0" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="The use of Betapace AF (sotalol hydrochloride" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="24:45" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.205.e.1" text="sotalol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0026289" phraseText="The use of Betapace AF (sotalol hydrochloride" preferredWord="Sotalol Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.205.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.205.e.1"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.209" text="Transfer to Betapace AF from Betapace" type="negative"><entity charOffset="29:37" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.209.e.0" text="betapace" type="Biomedical_Entity"><Normalization><mmtx cui="C0728751" phraseText="from Betapace" preferredWord="Betapace" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="12:23" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.209.e.1" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="Transfer to Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.209.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.209.e.0"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.210" text="Patients with a history of symptomatic AFIB/AFL who are currently receiving Betapace for the maintenance of normal sinus should be transferred to Betapace AF because of the significant differences in labeling (i.e., patient package insert, dosing administration, and safety information)." type="negative"><entity charOffset="76:84" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.210.e.0" text="betapace" type="Biomedical_Entity"><Normalization><mmtx cui="C0728751" phraseText="Betapace for the maintenance of normal sinus" preferredWord="Betapace" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="146:157" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.210.e.1" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="transferred to Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.210.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.210.e.1"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.211" text="Transfer to Betapace AF from Other Antiarrhythmic Agents" type="negative"><entity charOffset="12:23" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.211.e.0" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="Transfer to Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="35:56" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.211.e.1" text="antiarrhythmic agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003195" phraseText="from Other Antiarrhythmic Agents" preferredWord="Anti-Arrhythmia Agents" semType="phsu"/><RxNorm RxCui="883"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.211.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.211.e.1"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.212" text="Before starting Betapace AF, previous antiarrhythmic therapy should generally be withdrawn under careful monitoring for a minimum of 2-3 plasma half-lives if the patient's clinical condition permits (see Drug Interactions). " type="negative"><entity charOffset="16:27" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.212.e.0" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="starting Betapace AF," preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="38:52" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.212.e.1" text="antiarrhythmic" type="Biomedical_Entity"><Normalization><mmtx cui="C0003195" phraseText="previous antiarrhythmic therapy" preferredWord="Anti-Arrhythmia Agents" semType="phsu"/><RxNorm RxCui="883"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.212.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.212.e.1"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.214" text="After discontinuation of amiodarone, Betapace AF should not be initiated until the QT interval is normalized (see WARNINGS)." type="negative"><entity charOffset="37:48" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.214.e.0" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="Betapace AF" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="25:35" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.214.e.1" text="amiodarone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002598" phraseText="of amiodarone," preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.214.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.214.e.0"/></sentence><sentence id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216" text="Betapace AF Syrup 5 mg/mL can be compounded using Simple Syrup containing 0.1% sodium benzoate (Syrup, NF) available from Humco Laboratories as follows:" type="negative"><entity charOffset="0:11" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.0" text="betapace af" type="Biomedical_Entity"><Normalization><mmtx cui="C0875976" phraseText="Betapace AF Syrup 5 mg/mL" preferredWord="Betapace AF" semType="phsu, orch"/><RxNorm RxCui="224909"/></Normalization></entity><entity charOffset="79:94" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.1" text="sodium benzoate" type="Biomedical_Entity"><Normalization><mmtx cui="C0142805" phraseText="0.1% sodium benzoate" preferredWord="Sodium Benzoate" semType="phsu, orch"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="122:127" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.2" text="humco" type="Biomedical_Entity"><Normalization><mmtx cui="C2364853" phraseText="NF) available from Humco Laboratories" preferredWord="Humco" semType="phsu, orch"/><RxNorm RxCui="806521"/></Normalization></entity><entity charOffset="50:62" id="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.3" text="simple syrup" type="Biomedical_Entity"><Normalization><mmtx cui="C0727860" phraseText="Simple Syrup" preferredWord="SIMPLE SYRUP" semType="phsu"/><RxNorm RxCui="224080"/></Normalization></entity><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.1"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.2"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.0" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.3"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.1" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.2"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.3" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.1"/><pair ddi="false" e1="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.3" e2="Dailymed.21aea811-f47d-4a44-a552-dfc46d2773bf.s.216.e.2"/></sentence><positiveExamples number="20"/><negativeExamples number="59"/></document>